<PAGE>
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________________________
FORM 10-KSB/A
(Mark One)
/X/ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the fiscal year ended December 31, 1996
OR
/ / TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from___________ to ___________
Commission file number 0-25344
_______________________________________
NATIONAL MEDICAL FINANCIAL SERVICES CORPORATION
(Name of small business issuer)
Nevada 25-1741216
(State or other jurisdiction of) (I.R.S. Employer Identification No.)
Incorporation or organization
1315 Greg Street, Suite 103
Sparks, Nevada 89431
(Address of principal executive offices) (Zip Code)
702-356-2315
(Issuer's telephone number)
Securities registered pursuant to Section 12(b) of the Exchange Act:
None
Securities registered pursuant to Section 12(g) of the Exchange Act:
Common Stock
Check whether the issuer (1) has filed all reports required to be filed
by Section 13 or 15(b) of the Exchange Act during the past 12 months (or for
such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days.
Yes X No
----- -----
Check if there is no disclosure of delinquent filers in response to Item
405 of Regulation S-B contained in this form, and no disclosure will be
contained, to the best of registrant's knowledge, in definitive proxy or
information statements incorporated by reference in Part III of this Form
10-KSB or any amendment to this Form 10-KSB. /X/
State issuer's revenues for its most recent fiscal year. $9,215,117
----------
State the aggregate market value of the voting stock held by
non-affiliates of the registrant computed by reference to the price at which
the stock was sold, or the average bid and asked prices of such equity, as of
March 27, 1997. $27,131,465
-----------
State the number of shares outstanding of each of the issuer's classes of
equity stock, as of March 27, 1997. 15,015,316
----------
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the following documents are incorporated herein by reference:
Part III - The registrant's definitive Proxy Statement for its Annual
Meeting of Stockholders, to be filed not later than 120 days after the close
of the fiscal year.
Transitional Small Business Disclosure Format: Yes No X
----- -----
PORTIONS AMENDED
The Cover Page of the Company's Annual Report on Form 10-KSB is amended
to state the aggregate market value of the voting stock held by
non-affiliates of the registrant as $27,131,465 and to state the number of
shares outstanding of each of the issuers' classes of equity stock as
15,015,316.
<PAGE>
SIGNATURES
In accordance with Section 13 or 15(d) of the Securities Exchange Act of
1934, the Registrant caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
NATIONAL MEDICAL FINANCIAL SERVICES
CORPORATION
By: /s/ Douglas R. Colkitt, M.D.
------------------------------------
Douglas R. Colkitt, M.D., Chairman,
President and Chief Executive Officer
SIGNATURES
In accordance with the Securities Exchange Act of 1934, this report
has been signed below by the following persons on behalf of the Registrant and
in the capacities and on the dates indicated.
<TABLE>
<CAPTION>
Signatures Title Date
- ---------- ----- ----
<S> <C> <C>
/s/ Douglas R. Colkitt, M.D. Chairman, President and March 28, 1997
- ---------------------------- Chief Executive Officer
Douglas R. Colkitt, M.D. (Principal Executive Officer)
/s/ Robert W. Horner, Jr. Vice President, Chief Financial Officer, March 28, 1997
- ---------------------------- Treasurer and Secretary (Principal
Robert W. Horner, Jr. Financial and Accounting Officer)
/s/ Jude J. Spak Director March 28, 1997
- ----------------------------
Jude J. Spak
/s/ Richard L. Flickinger Director March 28, 1997
- ----------------------------
Richard L. Flickinger
/s/ Robert M. Colkitt Director March 28, 1997
- ----------------------------
Robert M. Colkitt
</TABLE>
